Clinical Trials Sponsored by Sublimity Therapeutics Holdco Limited

Total 1 results

Sublimity Therapeutics Holdco Limited
Dr. Falk Pharma GmbH

Terminated

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative

United States, United Kingdom, Serbia, Canada, Russian Federation, Poland, Israel, Romania, Ireland, Spain, Hungary, Ukraine, Belarus, Italy, Bulgaria, France, Germany

3

Subscribe